Hinge Health announced that it launched its Enso 3 FDA-cleared wireless device for reducing musculoskeletal pain. San Francisco-based Hinge designed the device to deliver electrical nerve stimulation for non-invasive, non-addictive pain relief within minutes. The company plans to start the first shipments of the new Enso device this month. It then expects wider availability to […]
Neuromodulation/Neurostimulation
Discure raises $16M for bioelectronic spine implant
Discure Technologies announced today that it raised $11 million in an oversubscribed Series A, adding to a separate $5 million fundraising. The Petach-Tivka, Israel-based company brought in $5 million through a Simple Agreement for Future Equity (SAFE) raise. BOLD Capital Partners, Supernova Invest and Sanara Capital led the company’s $11 million Series A. Multiple U.S. […]
DeepWell DTx wins FDA clearance of software development kit, with first indications for stress reduction and hypertension
DeepWell Digital Therapeutics (DTx) has won FDA 510(k) clearance of technology to be used in immersive media like video games for stress reduction and as an adjunctive treatment for high blood pressure. The digital therapeutics developer plans to make its biofeedback software development kit (SDK) available to video game developers and media companies to embed […]
ElectroCore CFO retires, promotes replacement from within
ElectroCore announced this week that Chief Financial Officer Brian Posner will be retiring on October 4. In conjunction with his retirement, the vagus nerve stimulator company announced it promoted Chief Strategy Officer Joshua Lev to the CFO role, effective as of Posner’s retirement. Lev has been with the company since February 2020, when he was […]
Neurostim company Phagenesis picks new CEO
Phagenesis, a developer of neurostimulation for treating swallowing dysfunction announced today that it appointed Chad Hoskins as CEO. A seasoned executive, Hoskins brings decades of experience scaling therapies, driving U.S. growth and delivering on strategic objectives. He joins the company around six months after it raised $42 million in a Series D financing round. The […]
NeuroPace adds former Boston Scientific DBS marketing head, former Magnus Medical CEO as VPs
NeuroPace (Nasdaq:NPCE) announced today that it appointed Brett Wingeier as its new VP of R&D and Katie Keller as VP of marketing. Both appointments made by the maker of the FDA-approved RNS system for treating epilepsy go into effect immediately. Wingeier’s experience includes a stint as co-founder, CTO and CEO of Magnus Medical, another neurostimulation […]
Abbott initiates study of deep-brain stimulation for treatment-resistant depression
Abbott announced today that it initiated a pivotal clinical trial evaluating its deep-brain stimulation (DBS) system in the treatment of depression. The TRANSCEND study looks at DBS in the management of treatment-resistant depression (TRD), a form of major depressive disorder. Abbott won FDA breakthrough device designation to explore the use of DBS for TRD more […]
CVRx adds two new faces to its board as long-serving member departs
CVRx (Nasdaq:CVRX) announced today that it appointed Kevin Ballinger and Mitch Hill to its board of directors, effective immediately. “We are thrilled to welcome Kevin and Mitch to our Board of Directors,” said Kevin Hykes, President and CEO of CVRx. “Their extensive experience in the medical device industry, coupled with their strong track records driving […]
Onward receives $1.1M Christopher & Dana Reeve Foundation grant to expand BCI study
Onward Medical announced today that it received a grant from the Christopher & Dana Reeve Foundation to support an ongoing study. The $1.1 million grant supports the expansion of an ongoing early clinical feasibility study of the use of the company’s brain-computer interface (BCI). Onward’s study evaluates the use of BCI to restore thought-driven use […]
Another 5 brain-computer interface companies you should know
Over the past several months, there have been a number of significant developments in the brain-computer interface (BCI) space. The likes of Neuralink, Synchron and Precision Neuroscience, among others, continue to advance their platforms. Some even began clinical trials, while many more companies are vying to be the first to bring a BCI to market. […]
FDA approves electrical nerve stim tech from Neuros Medical
Neuros Medical announced today that it received FDA approval for its Altius direct electrical nerve stimulation system. The FDA cleared Altius as an aid in the management of chronic intractable phantom and residual lower limb post-amputation pain in adult amputees. Labeling came on the back of results from the QUEST study, which met all primary […]
